| Tabasum Amir, MD | |
|
205 W Touhy Ave Ste 104, Park Ridge, IL 60068-4218 | |
| (847) 384-3551 | |
| Not Available |
| Full Name | Tabasum Amir |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 205 W Touhy Ave Ste 104, Park Ridge, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891883641 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 036114879 (Illinois) | Primary |
| Entity Name | Adventist Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033490651 PECOS PAC ID: 0244135762 Enrollment ID: O20040127000064 |
News Archive
An international team of researchers led by scientists from the University of the Witwatersrand's Evolutionary Studies Institute and the South African Centre for Excellence in PalaeoSciences today announced in two papers, published in the South African Journal of Science, the discovery of the most ancient evidence for cancer and bony tumours yet described in the human fossil record.
Hospital-acquired infections are the leading cause of potentially preventable mortality among pediatric patients, according to a study of pediatric patient-safety incidents issued today by HealthGrades, the leading independent health care ratings organization.
Oncolytics Biotech Inc. today provided an update on its Phase III trial of REOLYSIN in combination with carboplatin and paclitaxel for the treatment of head and neck cancers (REO 018).
Flamel Technologies announced today that it has entered into a license agreement with a leading specialty pharmaceutical company for development and commercialization of two molecules for pain indications.
On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Building the Oral Health Care Workforce: Multipronged Research on Dental Therapy" will take place to help attendees understand opportunities for effective utilization of new workforce models in nontraditional settings within the oral health care community.
› Verified 5 days ago
| Entity Name | Vna Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508826983 PECOS PAC ID: 6901879311 Enrollment ID: O20041004000258 |
News Archive
An international team of researchers led by scientists from the University of the Witwatersrand's Evolutionary Studies Institute and the South African Centre for Excellence in PalaeoSciences today announced in two papers, published in the South African Journal of Science, the discovery of the most ancient evidence for cancer and bony tumours yet described in the human fossil record.
Hospital-acquired infections are the leading cause of potentially preventable mortality among pediatric patients, according to a study of pediatric patient-safety incidents issued today by HealthGrades, the leading independent health care ratings organization.
Oncolytics Biotech Inc. today provided an update on its Phase III trial of REOLYSIN in combination with carboplatin and paclitaxel for the treatment of head and neck cancers (REO 018).
Flamel Technologies announced today that it has entered into a license agreement with a leading specialty pharmaceutical company for development and commercialization of two molecules for pain indications.
On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Building the Oral Health Care Workforce: Multipronged Research on Dental Therapy" will take place to help attendees understand opportunities for effective utilization of new workforce models in nontraditional settings within the oral health care community.
› Verified 5 days ago
| Entity Name | Excellent Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215223623 PECOS PAC ID: 1355506817 Enrollment ID: O20120706000494 |
News Archive
An international team of researchers led by scientists from the University of the Witwatersrand's Evolutionary Studies Institute and the South African Centre for Excellence in PalaeoSciences today announced in two papers, published in the South African Journal of Science, the discovery of the most ancient evidence for cancer and bony tumours yet described in the human fossil record.
Hospital-acquired infections are the leading cause of potentially preventable mortality among pediatric patients, according to a study of pediatric patient-safety incidents issued today by HealthGrades, the leading independent health care ratings organization.
Oncolytics Biotech Inc. today provided an update on its Phase III trial of REOLYSIN in combination with carboplatin and paclitaxel for the treatment of head and neck cancers (REO 018).
Flamel Technologies announced today that it has entered into a license agreement with a leading specialty pharmaceutical company for development and commercialization of two molecules for pain indications.
On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Building the Oral Health Care Workforce: Multipronged Research on Dental Therapy" will take place to help attendees understand opportunities for effective utilization of new workforce models in nontraditional settings within the oral health care community.
› Verified 5 days ago
| Entity Name | Amer I Alhussaini Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124402466 PECOS PAC ID: 9638484553 Enrollment ID: O20150820010886 |
News Archive
An international team of researchers led by scientists from the University of the Witwatersrand's Evolutionary Studies Institute and the South African Centre for Excellence in PalaeoSciences today announced in two papers, published in the South African Journal of Science, the discovery of the most ancient evidence for cancer and bony tumours yet described in the human fossil record.
Hospital-acquired infections are the leading cause of potentially preventable mortality among pediatric patients, according to a study of pediatric patient-safety incidents issued today by HealthGrades, the leading independent health care ratings organization.
Oncolytics Biotech Inc. today provided an update on its Phase III trial of REOLYSIN in combination with carboplatin and paclitaxel for the treatment of head and neck cancers (REO 018).
Flamel Technologies announced today that it has entered into a license agreement with a leading specialty pharmaceutical company for development and commercialization of two molecules for pain indications.
On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Building the Oral Health Care Workforce: Multipronged Research on Dental Therapy" will take place to help attendees understand opportunities for effective utilization of new workforce models in nontraditional settings within the oral health care community.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tabasum Amir, MD 9475 Harrison St, Des Plaines, IL 60016-1542 Ph: (847) 298-1445 | Tabasum Amir, MD 205 W Touhy Ave Ste 104, Park Ridge, IL 60068-4218 Ph: (847) 384-3551 |
News Archive
An international team of researchers led by scientists from the University of the Witwatersrand's Evolutionary Studies Institute and the South African Centre for Excellence in PalaeoSciences today announced in two papers, published in the South African Journal of Science, the discovery of the most ancient evidence for cancer and bony tumours yet described in the human fossil record.
Hospital-acquired infections are the leading cause of potentially preventable mortality among pediatric patients, according to a study of pediatric patient-safety incidents issued today by HealthGrades, the leading independent health care ratings organization.
Oncolytics Biotech Inc. today provided an update on its Phase III trial of REOLYSIN in combination with carboplatin and paclitaxel for the treatment of head and neck cancers (REO 018).
Flamel Technologies announced today that it has entered into a license agreement with a leading specialty pharmaceutical company for development and commercialization of two molecules for pain indications.
On March 22, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, a symposium titled "Building the Oral Health Care Workforce: Multipronged Research on Dental Therapy" will take place to help attendees understand opportunities for effective utilization of new workforce models in nontraditional settings within the oral health care community.
› Verified 5 days ago
Dr. Mita Patel, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1775 Dempster St, East Pavilion Suite 113, Park Ridge, IL 60068 Phone: 847-723-5900 Fax: 847-723-2178 |